Arlo director executes 10b5-1 sale of 60,787 shares at $16.61

Rhea-AI Filing Summary

Prashant Aggarwal, a director of Arlo Technologies, Inc. (ARLO), reported a sale of 60,787 shares of Arlo common stock on 08/14/2025 under a Rule 10b5-1 trading plan adopted May 15, 2025. The weighted average sale price was $16.6127 with individual trade prices ranging from $16.41 to $17.07. After the sales, the reporting person beneficially owned 10,520 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating pre-authorization and reduced likelihood of opportunistic trading
• Clear disclosure of weighted average price ($16.6127) and price range ($16.41–$17.07), providing execution transparency
• Form 4 filed and signed promptly (attorney-in-fact signature dated 08/15/2025), meeting disclosure requirements

Negative

• Large reduction in beneficial holdings: 60,787 shares sold, leaving only 10,520 shares beneficially owned, which materially lowers the reporting person’s stake
• Potential perception issue: Significant insider sale may be interpreted unfavorably by some investors despite 10b5-1 plan status

Insights

Financial Analyst

TL;DR: Director executed a pre-planned sale of most holdings, yielding proceeds at a $16.61 average price; residual stake is modest.

The sale of 60,787 shares under a Rule 10b5-1 plan indicates the transactions were pre-authorized and not opportunistic trades following material nonpublic information disclosed after the plan date. The weighted average price of $16.6127 and the reported price range provide transparency on execution. The residual beneficial ownership of 10,520 shares is a small remaining position, which may modestly reduce insider alignment with shareholders but is a routine disclosure rather than a company performance signal.

Corporate Governance Expert

TL;DR: Filing documents a compliant, pre-arranged insider sale; disclosure and signature by attorney-in-fact follow Form 4 standards.

The Form 4 clearly flags the use of a 10b5-1 plan adopted May 15, 2025, satisfying affirmative defense disclosure. The submission includes price range and average price and notes willingness to provide full price-by-price details if requested. The filing appears procedurally complete and timely, with an attorney-in-fact signature dated 08/15/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aggarwal Prashant

(Last) (First) (Middle)

C/O ARLO TECHNOLOGIES, INC.

5770 FLEET STREET

(Street)

CARLSBAD CA 92008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arlo Technologies, Inc. [ ARLO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2025		S(1)		60,787	D	$16.6127(2)	10,520	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2025.

2. The weighted average sale price for the transaction reported was $16.6127, and the range of prices were between $16.41 and $17.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

	/s/ Brian Busse, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ARLO director Prashant Aggarwal report on Form 4?

He reported the sale of 60,787 shares of Arlo common stock on 08/14/2025 under a Rule 10b5-1 trading plan.

At what price were the ARLO shares sold?

The weighted average sale price was $16.6127, with individual trade prices ranging from $16.41 to $17.07.

How many ARLO shares does the reporting person own after the sale?

10,520 shares of common stock were beneficially owned following the reported transactions.

When was the 10b5-1 plan adopted for these ARLO sales?

The Rule 10b5-1 trading plan was adopted on May 15, 2025, as stated on the Form 4.

Who signed the Form 4 for this ARLO filing?

The Form 4 was signed by Brian Busse, Attorney-in-Fact, on 08/15/2025.